FdaApplication
NDA 022101
Identifiers
- fda_app_no: NDA022101
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA PHARMACEUTICALS LP |
| application_type | NDA |
| approval_date | 2008-02-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEXIUM | ESOMEPRAZOLE MAGNESIUM | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
1 product